You're going to hear more about "aspirin resistance
You're going to hear more about "aspirin resistance."
Tests suggest that about 10% of patients are resistant to aspirin's antiplatelet effects...and therefore might not benefit from using low-dose aspirin to prevent cardiovascular disease.
Now a study suggests that these patients are up to 3 times more likely to die of cardiovascular disease.
Get concise, unbiased advice for effective drug therapy, plus CE/CME
Prescriber's Letter includes:
- 12 issues every year, with brief articles about new meds and guidelines
- 48+ CE courses, including the popular CE-in-the-Letter
- Quick reference drug comparison charts
- Access to the entire archive
Already a subscriber? Log in
Volume pricing available. Get a quote